Faria Ricardo, Silva Bruno, Silva Catarina, Loureiro Pedro, Queiroz Ana, Fraga Sofia, Esteves Jorge, Mendes Diana, Fleming Rita, Vieira Luís, Gonçalves João, Faustino Paula
Departamento de Genética Humana, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal.
Serviço de Pediatria, Hospital Garcia de Orta, Almada, Portugal.
Blood Cells Mol Dis. 2016 Oct;61:10-5. doi: 10.1016/j.bcmd.2016.07.004. Epub 2016 Jul 22.
Hereditary hemochromatosis (HH) is an autosomal recessive disorder characterized by excessive iron absorption resulting in pathologically increased body iron stores. It is typically associated with common HFE gene mutation (p.Cys282Tyr and p.His63Asp). However, in Southern European populations up to one third of HH patients do not carry the risk genotypes. This study aimed to explore the use of next-generation sequencing (NGS) technology to analyse a panel of iron metabolism-related genes (HFE, TFR2, HJV, HAMP, SLC40A1, and FTL) in 87 non-classic HH Portuguese patients. A total of 1241 genetic alterations were detected corresponding to 53 different variants, 13 of which were not described in the available public databases. Among them, five were predicted to be potentially pathogenic: three novel mutations in TFR2 [two missense (p.Leu750Pro and p.Ala777Val) and one intronic splicing mutation (c.967-1G>C)], one missense mutation in HFE (p.Tyr230Cys), and one mutation in the 5'-UTR of HAMP gene (c.-25G>A). The results reported here illustrate the usefulness of NGS for targeted iron metabolism-related gene panels, as a likely cost-effective approach for molecular genetics diagnosis of non-classic HH patients. Simultaneously, it has contributed to the knowledge of the pathophysiology of those rare iron metabolism-related disorders.
遗传性血色素沉着症(HH)是一种常染色体隐性疾病,其特征为铁吸收过多,导致体内铁储存病理性增加。它通常与常见的HFE基因突变(p.Cys282Tyr和p.His63Asp)相关。然而,在南欧人群中,高达三分之一的HH患者不携带风险基因型。本研究旨在探索使用下一代测序(NGS)技术分析87例非典型HH葡萄牙患者的一组铁代谢相关基因(HFE、TFR2、HJV、HAMP、SLC40A1和FTL)。共检测到1241个基因改变,对应53种不同变异,其中13种在现有公共数据库中未被描述。其中,5种被预测可能具有致病性:TFR2中的3种新突变[2种错义突变(p.Leu750Pro和p.Ala777Val)和1种内含子剪接突变(c.967 - 1G>C)]、HFE中的1种错义突变(p.Tyr230Cys)以及HAMP基因5'-UTR中的1种突变(c.-25G>A)。此处报告的结果说明了NGS用于靶向铁代谢相关基因panel的有用性,作为一种可能具有成本效益的非典型HH患者分子遗传学诊断方法。同时,它有助于了解那些罕见的铁代谢相关疾病的病理生理学。